These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37870699)

  • 21. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
    Cheng B; Yu Q; Wang W
    J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer.
    Wang G; Wang D; Sun M; Liu X; Yang Q
    Int Immunopharmacol; 2020 Nov; 88():106931. PubMed ID: 32889237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
    Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.
    Guo G; Yu M; Xiao W; Celis E; Cui Y
    Cancer Res; 2017 May; 77(9):2292-2305. PubMed ID: 28280037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sweat Gland Tumor Microenvironment.
    Yuda Handaya A; Anwar SL; Fauzi AR; Werdana VAP
    Adv Exp Med Biol; 2020; 1296():259-274. PubMed ID: 34185298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolving landscape of N
    Gu Y; Wu X; Zhang J; Fang Y; Pan Y; Shu Y; Ma P
    Mol Ther; 2021 May; 29(5):1703-1715. PubMed ID: 33839323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer: a mirrored room between tumor bulk and tumor microenvironment.
    Hernández-Camarero P; López-Ruiz E; Marchal JA; Perán M
    J Exp Clin Cancer Res; 2021 Jun; 40(1):217. PubMed ID: 34183054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy.
    Zhang Z; Chen L; Chen H; Zhao J; Li K; Sun J; Zhou M
    EBioMedicine; 2022 Sep; 83():104207. PubMed ID: 35961204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
    Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukine-10 in ovarian cancer.
    Levin G; Gotlieb WH
    Chin Clin Oncol; 2024 Aug; 13(4):48. PubMed ID: 38735685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
    Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
    BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
    Li J; Wu J; Han J
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver Tumor Microenvironment.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Moris D; Pawlik TM
    Adv Exp Med Biol; 2020; 1296():227-241. PubMed ID: 34185296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into the Immune TME of adult-type diffuse gliomas.
    Richard Q; Laurenge A; Mallat M; Sanson M; Castro-Vega LJ
    Curr Opin Neurol; 2022 Dec; 35(6):794-802. PubMed ID: 36226710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment.
    Poon E; Mullins S; Watkins A; Williams GS; Koopmann JO; Di Genova G; Cumberbatch M; Veldman-Jones M; Grosskurth SE; Sah V; Schuller A; Reimer C; Dovedi SJ; Smith PD; Stewart R; Wilkinson RW
    J Immunother Cancer; 2017 Aug; 5(1):63. PubMed ID: 28807001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-Omics Profiling of the Tumor Microenvironment.
    Van Oekelen O; Laganà A
    Adv Exp Med Biol; 2022; 1361():283-326. PubMed ID: 35230695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.